STAMP+CBT App for Cancer Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a new phone app that helps people with cancer manage their pain. The app provides methods and tips for reducing pain through behavior changes. The study aims to see if the app is useful and easy to use for cancer patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must have an active prescription for at least one opioid medication for cancer pain. You cannot participate if you use transmucosal fentanyl.
Is the STAMP+CBT App for Cancer Pain safe for humans?
How does the STAMP+CBT app treatment for cancer pain differ from other treatments?
The STAMP+CBT app is unique because it combines stress management and cognitive-behavioral therapy (CBT) in a mobile application, allowing patients to manage their cancer pain and associated symptoms at home. This integrated approach can reduce the need for frequent clinic visits and provides a personalized, step-by-step assessment and management of pain and stress.678910
What data supports the effectiveness of the STAMP+CBT treatment for cancer pain?
Research shows that mobile health technologies, like the STAMP+CBT app, can effectively teach cancer patients pain coping skills, leading to reduced pain severity and improved self-management. These mobile interventions are as effective as traditional in-person methods and are more accessible, making them a promising option for managing cancer pain.1451112
Who Is on the Research Team?
Desiree Azizoddin, PsyD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for adults over 18 with chronic pain from cancer or its treatment, who are being treated at specific clinics and have a smartphone. They must be undergoing active cancer treatment or palliative care, have a pain score over 4, and take opioids for cancer pain (not post-surgical). Excluded are non-English speakers, hospitalized patients, those in remission or survivorship phase, with cognitive impairments, history of opioid misuse, enrolled in hospice or using transmucosal fentanyl.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the smartphone app and complete surveys at baseline and after 4 weeks
Post-intervention
Participants complete a survey at the end of the 2-week post-intervention period
Follow-up
Participants are monitored for feedback and overall acceptability of the app
What Are the Treatments Tested in This Trial?
Interventions
- STAMP+CBT application
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Palliative Care Research Center
Collaborator
National Palliative Care Research Center (NPCRC)
Collaborator